BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 12, 2011
 |  BC Week In Review  |  Company News  |  Deals

MDxHealth, University Hospital Bonn deal

The university will use MDxHealth's PredictMDx for Glioblastoma to screen patients for the university's Phase III CeTeG trial, which will enroll patients with a methylated O-6-methylguanine ...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >